159 related articles for article (PubMed ID: 26797414)
61. KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.
Feng FL; Yu Y; Liu C; Zhang BH; Cheng QB; Li B; Tan WF; Luo XJ; Jiang XQ
Int J Clin Exp Pathol; 2014; 7(1):80-91. PubMed ID: 24427328
[TBL] [Abstract][Full Text] [Related]
62. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
63. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2014 Jul; 45(1):322-32. PubMed ID: 24806290
[TBL] [Abstract][Full Text] [Related]
64. Adeno-associated virus mediated gene transfer of Shepherdin inhibits gallbladder carcinoma growth in vitro and in vivo.
Zhu A; Ren Y; Wang N; Jin Q; Zhang D; Yang G; Wang Q
Gene; 2015 Nov; 572(1):87-94. PubMed ID: 26143116
[TBL] [Abstract][Full Text] [Related]
65. miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway.
Ouyang B; Pan N; Zhang H; Xing C; Ji W
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649824
[TBL] [Abstract][Full Text] [Related]
66. [Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential].
Liu YB; He XW; Wang JW; Li JT; Li KQ; Liu FB; Xue JF; Zhu JH; Li B; Peng SY
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2117-21. PubMed ID: 17064616
[TBL] [Abstract][Full Text] [Related]
67. [Research on resveratrol's effects on suppressing growth and inducing apoptosis of GBC cells].
Sheng L; An L; He Y; Fan G; Yuan Y
Zhong Yao Cai; 2005 Jun; 28(6):489-91. PubMed ID: 16209266
[TBL] [Abstract][Full Text] [Related]
68. Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.
Grosset AA; Labrie M; Gagné D; Vladoiu MC; Gaboury L; Doucet N; St-Pierre Y
BMC Cancer; 2014 Nov; 14():801. PubMed ID: 25367122
[TBL] [Abstract][Full Text] [Related]
69. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.
Gao Y; Wang Z; Zhu Y; Zhu Q; Yang Y; Jin Y; Zhang F; Jiang L; Ye Y; Li H; Zhang Y; Liang H; Xiang S; Miao H; Liu Y; Hao Y
Cancer Sci; 2019 Nov; 110(11):3510-3519. PubMed ID: 31487418
[TBL] [Abstract][Full Text] [Related]
70. Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines.
Wang S; Liu C; Liu X; He Y; Shen D; Luo Q; Dong Y; Dong H; Pang Z
Tumour Biol; 2017 Oct; 39(10):1010428317718192. PubMed ID: 29034777
[TBL] [Abstract][Full Text] [Related]
71. Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway.
Lv X; Lin Y; Zhu X; Cai X
Pharm Biol; 2023 Dec; 61(1):556-567. PubMed ID: 36994917
[TBL] [Abstract][Full Text] [Related]
72. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
Bian R; Dang W; Song X; Liu L; Jiang C; Yang Y; Li Y; Li L; Li X; Hu Y; Bao R; Liu Y
Int J Biol Sci; 2021; 17(9):2167-2180. PubMed ID: 34239347
[TBL] [Abstract][Full Text] [Related]
73. Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response.
Zhang Y; Liu Y; Duan J; Wang H; Zhang Y; Qiao K; Wang J
Cell Cycle; 2019 Dec; 18(23):3337-3350. PubMed ID: 31599189
[TBL] [Abstract][Full Text] [Related]
74. Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy.
Maurya SK; Tewari M; Sharma B; Shukla HS
Korean J Intern Med; 2013 Sep; 28(5):573-8. PubMed ID: 24009453
[TBL] [Abstract][Full Text] [Related]
75. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
García P; Bizama C; Rosa L; Espinoza JA; Weber H; Cerda-Infante J; Sánchez M; Montecinos VP; Lorenzo-Bermejo J; Boekstegers F; Dávila-López M; Alfaro F; Leiva-Acevedo C; Parra Z; Romero D; Kato S; Leal P; Lagos M; Roa JC
Biol Res; 2020 Apr; 53(1):13. PubMed ID: 32293552
[TBL] [Abstract][Full Text] [Related]
76. Experimental chemotherapy for xenograft cell lines of human bile duct and gall bladder cancers in nude mice.
Tsubono M; Nio Y; Tseng CC; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
J Surg Oncol; 1992 Dec; 51(4):274-80. PubMed ID: 1434661
[TBL] [Abstract][Full Text] [Related]
77. Targeting gallbladder cancer: a pathway based perspective.
Baichan P; Naicker P; Devar JWS; Smith M; Candy GP; Nweke E
Mol Biol Rep; 2020 Mar; 47(3):2361-2369. PubMed ID: 32020429
[TBL] [Abstract][Full Text] [Related]
78. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT.
Ye J; Qi L; Liang J; Zong K; Liu W; Li R; Feng R; Zhai W
J Cancer; 2021; 12(12):3548-3557. PubMed ID: 33995632
[TBL] [Abstract][Full Text] [Related]
79. Recognition of potential therapeutic role of 2-hydroxy-3-methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis.
Jin H; Cui M
Fundam Clin Pharmacol; 2022 Apr; 36(2):350-362. PubMed ID: 34850442
[TBL] [Abstract][Full Text] [Related]
80. Parthenolide induces gallbladder cancer cell apoptosis via MAPK signalling.
Obulkasim H; Aji G; Abudoula A; Liu Y; Duan S
Ann Med Surg (Lond); 2024 Apr; 86(4):1956-1966. PubMed ID: 38576937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
